- Shin Poong has established a number of overseas branches.
- SHINPOONG PHARM.CO.,LTD.
R&D
Pipeline
| Preclinical | Phase 1 | Phase 2 | Phase 3/4 | Marketed | |
|---|---|---|---|---|---|
| Cardiovascular disease |
SP-8416 Heart failure |
SP-8356 Stroke, Atherosclerosis |
Otaplimastat Acute ischemic stroke |
CandeAmlo® Hypertension |
|
|
Otaplimastat ALS Additional Indication |
CandeAmlo plus™ Hypertension |
EzeRosu® Hyperlipidemia |
|||
|
SP-8257 Stroke, Atherosclerosis |
|||||
| Bone related disease |
Hyalflex® Osteoarthritis |
||||
|
Hyaltop® Osteoarthritis |
|||||
| Medical Device |
SP5V005 Anti-adhesion, Additional Function |
Medicurtain® Anti-adhesion |
|||
| Infectious disease |
Pyramax® tablets COVID-19 Drug repurposing |
Pyramax® tablets Malaria WHO-MMV |
|||
|
Pyramax® granules Malaria WHO-MMV |
- Head office : 161, Yeoksam-ro, Gangnam-gu, Seoul, 06246, Republic of Korea
- Tel : 82-2-2189-3400
- Factory : 434-4 Moknae-dong Danwon-gu Ansan, Republic of Korea
- Tel : 82-31-491-6191~2
- E-mail: sptrade@shinpoong.co.kr
- COPYRIGHT(C) SHINPOONG.CO,.LTD ALL RIGHTS RESERVED.
